Regulation is not preventing continuous decision readiness. Increasingly, it is defining the conditions under which it can be ...

We continue to see enormous technological and scientific progress in the area of drug discovery, with the promise of AI to upend traditional models and approaches becoming more fully realized by the ...

The global clinical trial management services market is projected to grow from $36.2 billion in 2025 to $68.4 billion by 2033, a new Research and Markets report finds, with North America holding 34.7% ...

Clinical research sites using RealTime's eSource application will gain expanded access to IgniteData's Archer platform.

Thought LeadersAoife Hayes, Kevin O'Regan & Julie ScanlonClinical Trials Assitant, Operations Manager & Quality Assurance ManagerAtlantia Clinical Trials Food clinical trials may not be as familiar to ...

Despite rapid growth, only 9.2% of DCTs are multiregional and over 80% single-country, indicating challenges in international implementation. 2 With regulatory agencies 4–7 underscoring risk-based ...

India, Oct. 22 -- Jennifer Clodia D's experience in India and the UK offers a perspective on the technical work that helps ...

Yonalink is a technology company specializing in clinical trial data management. They provide a platform that streamlines the process of collecting, managing, and transferring clinical trial data, ...

Faculty in this hub lead the design, coordination, and analysis of clinical trials for cancer treatment, survivorship, vaccine efficacy, infectious disease prevention and treatment, and cancer ...

The QSU Clinical Trials Program stands at the forefront of designing and implementing clinical trials. As the largest group of biostatisticians within Stanford Medicine, we are leading efforts in AI ...

New Report values decentralised clinical trials at $8bn in 2025, with hybrid models taking 54.1% and North America 44.2%, though data integrity and patchy regulation across regions still trouble IQVIA ...

Poster presentation to highlight the Phase 1a clinical evaluation of TTX-MC138 in patients with advanced solid tumors. BOSTON, Oct. 19, 2026 /PRNewswire/ -- TransCode Therapeutics ...